Vancouver, BC Biotechnology and Pharmaceutical Companies directory and employer contacts list
The following Vancouver, BC, Canada Biotechnology and Pharmaceutical Companies are among the many key British Columbia organizations listed in the JobPro Directory.Try the JobPro Directory today for free for more contacts, email addresses, phone numbers, mini-biographies and detailed company information from this and over 80 other industries across British Columbia.
LifeSciences British Columbia / LifeSciences BC - 900 - 1188 West Georgia Street, Vancouver, BC
supports and represents the biotechnology community of British Columbia through leadership, advocacy, promotion of BC's world-class science and biotechnology industry, and via facilitation of partnering and investment into British Columbia's biotechnology sector
Po On Yeung, Manager, Membership
LifeSciences British Columbia / LifeSciences BC
900 - 1188 West Georgia Street
Vancouver BC V6E 4A2
Tel. 604 602-527l (Replace '7l' with '61') - direct
Tel. 604 669-997l (Replace '7l' with '09')
Fax. 604 669-997l (Replace '7l' with '12')
eung@lifesciencesbc.bG (Replace 'bG' with 'ca')www.lifesciencesbc.ca
Po On is the primary person to contact for information about membership with LifeSciences British Columbia.
Po On holds a BSc from Simon Fraser University with a major in Biological Sciences and a minor in Kinesiology. She earned a Co-Operative Education certificate alongside her degree for completing work terms with the British Columbia Institute of Technology, the University of British Columbia and the British Columbia Innovation Council.
www.google.com/local?f=q&hl=en&q=900+-+1188+West+Georgia+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=LifeSciences+British+Columbia+/+LifeSciences+BC+Vancouver
LifeSciences British Columbia / LifeSciences BC - 900 - 1188 West Georgia Street, Vancouver, BC
supports and represents the biotechnology community of British Columbia through leadership, advocacy, promotion of BC's world-class science and biotechnology industry, and via facilitation of partnering and investment into British Columbia's biotechnology sector
Jason Lesage, Manager, Communications and Public Relations
LifeSciences British Columbia / LifeSciences BC
900 - 1188 West Georgia Street
Vancouver BC V6E 4A2
Tel. 604 602-52uj (Replace 'uj' with '27') - direct
Tel. 604 669-99uj (Replace 'uj' with '09')
Fax. 604 669-99uj (Replace 'uj' with '12')
esage@lifesciencesbc.nG (Replace 'nG' with 'ca')www.lifesciencesbc.ca
Jason has over ten years of communications and public affairs experience in the private, government and not-for-profit sectors. Most recently, he worked in public affairs with Mitacs Inc., a leading not-for-profit organization that fosters R&D and innovation across Canada. Prior to Mitacs, Jason worked with the British Columbia Lottery Corporation, the Government of B.C. and the Mayor's Office in Vancouver.
Jason also volunteers his time as a Director with the Canadian Club of Vancouver, an organization that fosters fellowship among citizens and celebrates community stewardship. He holds a B.Sc. from the University of Victoria, a Certificate in Public Relations from Langara College and is in the midst of completing a Graduate Diploma in Business Administration from Simon Fraser University's Beedie School of Business.
www.google.com/local?f=q&hl=en&q=900+-+1188+West+Georgia+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=LifeSciences+British+Columbia+/+LifeSciences+BC+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageLifeSciences British Columbia / LifeSciences BC - 900 - 1188 West Georgia Street, Vancouver, BC
supports and represents the biotechnology community of British Columbia through leadership, advocacy, promotion of BC's world-class science and biotechnology industry, and via facilitation of partnering and investment into British Columbia's biotechnology sector
Don M. Enns, President
LifeSciences British Columbia / LifeSciences BC
900 - 1188 West Georgia Street
Vancouver BC V6E 4A2
Tel. 604 669-99r3 (Replace 'r3' with '09')
Fax. 604 669-99r3 (Replace 'r3' with '12')
nns@lifesciencesbc.Ql (Replace 'Ql' with 'ca')www.lifesciencesbc.ca
August 31, 2010 - Industry association LifeSciences British Columbia is pleased to announce the appointment of Mr. Don Enns as the new President of the organization effective September 7, 2010.
Don Enns has been a leader in British Columbia's life sciences industry for over 25 years, most recently as President and CEO of CANTEST Ltd., a BC-headquartered global organization providing professional analytical and clinical services in support of environmental quality, pharmaceutical, biotechnology and food safety industries as well as related projects for business and government.
Through inspired leadership, impressive growth and industry-leading business practices, Mr. Enns helped the organization earn a spot amongst the 50 Best Managed Companies in Canada and to be recognized as one of BC's 25 Best Companies to work for.
Don is a director of numerous local for-profit companies as well as several non-profit organizations involved with national standardization, trade, education, community affairs, and public health.
He has overseen expansion into the European and Southeast Asian markets; been responsible for merger & acquisition activity; and consulted for international agencies such as the UN Development Programme. He currently serves as a Director or Committee Advisor to Genome British Columbia, the World Wildlife Fund and two UBC faculties amongst other organizations.
Mr. Enns received his MBA from UBC in 1987 and his Bachelor of Science Chemistry from TWU in 1982.
www.google.com/local?f=q&hl=en&q=900+-+1188+West+Georgia+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=LifeSciences+British+Columbia+/+LifeSciences+BC+Vancouver
LifeSciences British Columbia / LifeSciences BC - 900 - 1188 West Georgia Street, Vancouver, BC
supports and represents the biotechnology community of British Columbia through leadership, advocacy, promotion of BC's world-class science and biotechnology industry, and via facilitation of partnering and investment into British Columbia's biotechnology sector
Rosine Hage-Moussa, Manager, Programs & Outreach
LifeSciences British Columbia / LifeSciences BC
900 - 1188 West Georgia Street
Vancouver BC V6E 4A2
Tel. 604 602-52Fo (Replace 'Fo' with '28') - direct
Tel. 604 669-99Fo (Replace 'Fo' with '09')
Fax. 604 669-99Fo (Replace 'Fo' with '12')
age@lifesciencesbc.xU (Replace 'xU' with 'ca')www.lifesciencesbc.ca
www.google.com/local?f=q&hl=en&q=900+-+1188+West+Georgia+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=LifeSciences+British+Columbia+/+LifeSciences+BC+Vancouver
LifeSciences British Columbia / LifeSciences BC - 900 - 1188 West Georgia Street, Vancouver, BC
supports and represents the biotechnology community of British Columbia through leadership, advocacy, promotion of BC's world-class science and biotechnology industry, and via facilitation of partnering and investment into British Columbia's biotechnology sector
Lindsay Thom, Media Manager
LifeSciences British Columbia / LifeSciences BC
900 - 1188 West Georgia Street
Vancouver BC V6E 4A2
Tel. 604 602-52H7 (Replace 'H7' with '49') - direct
Tel. 604 669-99H7 (Replace 'H7' with '09')
Fax. 604 669-99H7 (Replace 'H7' with '12')
hom@bcic.IL (Replace 'IL' with 'ca') www.lifesciencesbc.ca
As Media Manager, Lindsay (@linds_thom) is responsible for the development and implementation of BCIC communication plans and activities including written communications, special events and media relations.
Lindsay's expertise working with various stakeholder groups including government and media come from previous work and volunteer roles in agency and not-for-profit. Prior to joining BCIC, Lindsay worked in PR & media relations at the Rick Hansen Foundation. She holds a Bachelors of Commerce degree in Marketing from the University of British Columbia.
www.google.com/local?f=q&hl=en&q=900+-+1188+West+Georgia+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=LifeSciences+British+Columbia+/+LifeSciences+BC+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageSolegear Bioplastics Inc. - 210 - 2386 East Mall, Vancouver, BC
Our business is focused on engineering, producing and distributing high-performance bioplastics. Our materials offer customized physical and mechanical properties for use in durable product applications. Solegear materials are suited for the Consumer Goods, Medical Devices, Electronics and Automotive industries.
We offer two distinct, customizable products:
* Polysole is a high performance plastic made from plants, that is designed to be compostable.
* Traverse is a biocomposite that can be made by mixing conventional plastic with plant-based fibers.
Troy Cressman, P.Eng., Business Development Manager
Solegear Bioplastics Inc.
210 - 2386 East Mall
Vancouver BC V6T 1Z3
Tel. 604 827-56Fu (Replace 'Fu' with '00')
Fax.
ressman@solegear.va (Replace 'va' with 'ca')
fo@solegear.va (Replace 'va' with 'ca')www.solegear.ca
www.linkedin.com/company/solegear-bioplastics-inc
www.google.com/local?f=q&hl=en&q=210+-+2386+East+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Solegear+Bioplastics+Inc.+Vancouver
Solegear Bioplastics Inc. - 210 - 2386 East Mall, Vancouver, BC
Our business is focused on engineering, producing and distributing high-performance bioplastics. Our materials offer customized physical and mechanical properties for use in durable product applications. Solegear materials are suited for the Consumer Goods, Medical Devices, Electronics and Automotive industries.
We offer two distinct, customizable products:
* Polysole is a high performance plastic made from plants, that is designed to be compostable.
* Traverse is a biocomposite that can be made by mixing conventional plastic with plant-based fibers.
Dr. Christo Stamboulides, Research & Development Manager
Solegear Bioplastics Inc.
210 - 2386 East Mall
Vancouver BC V6T 1Z3
Tel. 604 827-56Jv (Replace 'Jv' with '00')
Fax.
tamboulides@solegear.66 (Replace '66' with 'ca')fo@solegear.66 (Replace '66' with 'ca')www.solegear.ca
www.linkedin.com/company/solegear-bioplastics-inc
As Research & Development Manager, Christo is responsible for the laboratory testing at Solegear. With his experience as a chemical engineer, Christo ensures the quality, integrity, and compliance of Solegear materials.
Christo is a published Chemical Engineer. His most recent achievement was the research and development of polymeric techniques and products that significantly decrease snow and ice friction. This research provided a competitive edge to Canadian athletes for the 2010 Vancouver Olympic Games. His many previous publications are deeply concentrated on materials characterization.
Born in Vancouver, BC, raised in Greece, Christo holds a PhD in Chemical Engineering from the University of British Columbia.
www.google.com/local?f=q&hl=en&q=210+-+2386+East+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Solegear+Bioplastics+Inc.+Vancouver
Solegear Bioplastics Inc. - 210 - 2386 East Mall, Vancouver, BC
Our business is focused on engineering, producing and distributing high-performance bioplastics. Our materials offer customized physical and mechanical properties for use in durable product applications. Solegear materials are suited for the Consumer Goods, Medical Devices, Electronics and Automotive industries.
We offer two distinct, customizable products:
* Polysole is a high performance plastic made from plants, that is designed to be compostable.
* Traverse is a biocomposite that can be made by mixing conventional plastic with plant-based fibers.
Toby Reid, President, Founder & Chief Executive Officer
Solegear Bioplastics Inc.
210 - 2386 East Mall
Vancouver BC V6T 1Z3
Tel. 604 827-56jH (Replace 'jH' with '00')
Fax.
eid@solegear.Gf (Replace 'Gf' with 'ca')fo@solegear.Gf (Replace 'Gf' with 'ca')www.solegear.ca
www.linkedin.com/company/solegear-bioplastics-inc
Inspired by the notion that high performance engineering and environmental responsibility need not be mutually exclusive in the world of specialty materials, Toby founded Solegear in 2006. He leads the Company's overall development and commercialization efforts.
Toby brings a strong background in finance, sales & marketing, sustainability and technology commercialization to Solegear. Prior to founding Solegear, Toby was an Investment Associate in Toronto, ON, at RBC Dominion Securities Inc., Canada's largest investment dealer. He was also previously Corporate Communications Manager at Naturally Advanced Technologies Inc., a publicly traded cleantech startup, and E-Commerce Merchandiser for Mountain Equipment Co-op, Canada's largest outdoor retailer.
Born and raised in Toronto, Toby holds a Bachelor of Commerce in Finance & Marketing from Dalhousie University and is fluent in French.
www.google.com/local?f=q&hl=en&q=210+-+2386+East+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Solegear+Bioplastics+Inc.+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageSolegear Bioplastics Inc. - 210 - 2386 East Mall, Vancouver, BC
Our business is focused on engineering, producing and distributing high-performance bioplastics. Our materials offer customized physical and mechanical properties for use in durable product applications. Solegear materials are suited for the Consumer Goods, Medical Devices, Electronics and Automotive industries.
We offer two distinct, customizable products:
* Polysole is a high performance plastic made from plants, that is designed to be compostable.
* Traverse is a biocomposite that can be made by mixing conventional plastic with plant-based fibers.
Brian Gusko, Chief Financial Officer
Solegear Bioplastics Inc.
210 - 2386 East Mall
Vancouver BC V6T 1Z3
Tel. 604 827-56Qv (Replace 'Qv' with '00')
Fax.
usko@solegear.x2 (Replace 'x2' with 'ca')fo@solegear.x2 (Replace 'x2' with 'ca')www.solegear.ca
www.linkedin.com/company/solegear-bioplastics-inc
In his role as CFO, Brian is responsible for managing Solegear's financial operations. Brian's experience in financial planning and public markets complements Solegear's ambition of smart growth and operational expansion.
Prior to his position at Solegear, Brian was the CFO of UC Resources Ltd. and a Director at Grenville Gold Corp., both Toronto Stock Exchange traded mining and metals companies. From 1995 to 2010, Brian was the Capital Markets Advisor for Naturally Advanced Technologies Inc., a cleantech company also traded on the TSX.
Brian has worked in technology companies in Japan, South Africa, and Holland, and was a Market Analyst for the US Department of Commerce at an embassy posting, providing advice for American telecommunications and technology firms seeking to enter the Canadian market.
Brian holds a Bachelor of Arts in Biology from Carleton University, and an MBA from the University of Calgary and is a recipient of the Duke of Edinburgh Gold Award.
February 1, 2011 - Solegear Bioplastics Inc. is pleased to announce that Brian Gusko will be joining the executive team of the company as Chief Financial Officer. With an MBA from the University of Calgary, Mr. Gusko's international background as a financial controller, capital markets advisor and corporate governor includes roles as CFO, Investor Relations and Director for numerous publicly traded companies.
"We are delighted and honoured to welcome Brian to Solegear. With his appointment, we are in a stronger position to deliver on our objective of becoming an enduring leader in the global bioplastics industry," said Toby Reid, Solegear Founder & CEO. "Not only does Brian have an impressive track record of supporting the growth of entrepreneurial ventures, his business experience and financial expertise will be invaluable as Solegear moves ahead with more extensive operational, commercial and financial plans."
"What drew me to Solegear was not only its award-winning technology and strong marketing platforms, but also the company's commitment to integrity and sustainability throughout its operations," said Mr. Gusko. "My focus will be on financial planning, analysis of pubic markets and raising investment funds that will support Solegear and its ongoing transformation of the plastics industry. I'm excited to be joining the team as it gets going on the next phase of its development."
www.google.com/local?f=q&hl=en&q=210+-+2386+East+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Solegear+Bioplastics+Inc.+Vancouver
UBC Botanical Garden and Centre for Plant Research - 6804 SW Marine Drive, Vancouver, BC
University of British Columbia Botanical Garden curates a collection of ca. 12 000 plants representing approximately 8000 taxa from temperate regions around the world. Temperate forest plants of British Columbia, eastern North America and Asia are curated in woodland gardens, while a classic alpine garden displays the diverse flora of high-altitude regions of the world.
Sean Graham, Research Director
UBC Botanical Garden and Centre for Plant Research
6804 SW Marine Drive
Vancouver BC V6T 1Z4
Tel. 604 822-48C3 (Replace 'C3' with '16') - direct
Tel. 604 822-39C3 (Replace 'C3' with '28')
Fax. 604 822-20C3 (Replace 'C3' with '16')
an.graham@ubc.9D (Replace '9D' with 'ca')
tg@interchange.ubc.9D (Replace '9D' with 'ca')www.botanicalgarden.ubc.ca
www.google.com/local?f=q&hl=en&q=6804+SW+Marine+Drive,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Botanical+Garden+and+Centre+for+Plant+Research+Vancouver
UBC Botanical Garden and Centre for Plant Research - 6804 SW Marine Drive, Vancouver, BC
University of British Columbia Botanical Garden curates a collection of ca. 12 000 plants representing approximately 8000 taxa from temperate regions around the world. Temperate forest plants of British Columbia, eastern North America and Asia are curated in woodland gardens, while a classic alpine garden displays the diverse flora of high-altitude regions of the world.
Douglas Justice, Associate Director & Curator of Collections
UBC Botanical Garden and Centre for Plant Research
6804 SW Marine Drive
Vancouver BC V6T 1Z4
Tel. 604 690-44xW (Replace 'xW' with '05') - direct
Tel. 604 822-39xW (Replace 'xW' with '28')
Fax. 604 822-20xW (Replace 'xW' with '16')
uglas.justice@ubc.Ar (Replace 'Ar' with 'ca')tg@interchange.ubc.Ar (Replace 'Ar' with 'ca')www.botanicalgarden.ubc.ca
www.google.com/local?f=q&hl=en&q=6804+SW+Marine+Drive,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Botanical+Garden+and+Centre+for+Plant+Research+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageUBC Botanical Garden and Centre for Plant Research - 6804 SW Marine Drive, Vancouver, BC
University of British Columbia Botanical Garden curates a collection of ca. 12 000 plants representing approximately 8000 taxa from temperate regions around the world. Temperate forest plants of British Columbia, eastern North America and Asia are curated in woodland gardens, while a classic alpine garden displays the diverse flora of high-altitude regions of the world.
Patrick Lewis, Garden Director (UBC Biodiversity Collections Director)
UBC Botanical Garden and Centre for Plant Research
6804 SW Marine Drive
Vancouver BC V6T 1Z4
Tel. 604 862-586e (Replace '6e' with '05') - direct
Tel. 604 822-396e (Replace '6e' with '28')
Fax. 604 822-206e (Replace '6e' with '16')
trick.lewis@ubc.BX (Replace 'BX' with 'ca')tg@interchange.ubc.BX (Replace 'BX' with 'ca')www.botanicalgarden.ubc.ca
www.google.com/local?f=q&hl=en&q=6804+SW+Marine+Drive,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Botanical+Garden+and+Centre+for+Plant+Research+Vancouver
UBC Botanical Garden and Centre for Plant Research - 6804 SW Marine Drive, Vancouver, BC
University of British Columbia Botanical Garden curates a collection of ca. 12 000 plants representing approximately 8000 taxa from temperate regions around the world. Temperate forest plants of British Columbia, eastern North America and Asia are curated in woodland gardens, while a classic alpine garden displays the diverse flora of high-altitude regions of the world.
Katie Teed, Senior Marketing & Communication Manager (UBC Biodiversity Collections)
UBC Botanical Garden and Centre for Plant Research
6804 SW Marine Drive
Vancouver BC V6T 1Z4
Tel. 604 834-8676 (Replace '76' with '46') - direct
Tel. 604 822-3976 (Replace '76' with '28')
Fax. 604 822-2076 (Replace '76' with '16')
rden.marketing@ubc.vy (Replace 'vy' with 'ca')tg@interchange.ubc.vy (Replace 'vy' with 'ca')www.botanicalgarden.ubc.ca
www.google.com/local?f=q&hl=en&q=6804+SW+Marine+Drive,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Botanical+Garden+and+Centre+for+Plant+Research+Vancouver
UBC Botanical Garden and Centre for Plant Research - 6804 SW Marine Drive, Vancouver, BC
University of British Columbia Botanical Garden curates a collection of ca. 12 000 plants representing approximately 8000 taxa from temperate regions around the world. Temperate forest plants of British Columbia, eastern North America and Asia are curated in woodland gardens, while a classic alpine garden displays the diverse flora of high-altitude regions of the world.
Monica Tang, Administrative Manager
UBC Botanical Garden and Centre for Plant Research
6804 SW Marine Drive
Vancouver BC V6T 1Z4
Tel. 604 822-41mO (Replace 'mO' with '86') - direct
Tel. 604 822-39mO (Replace 'mO' with '28')
Fax. 604 822-20mO (Replace 'mO' with '16')
nica.tang@ubc.zh (Replace 'zh' with 'ca')tg@interchange.ubc.zh (Replace 'zh' with 'ca')www.botanicalgarden.ubc.ca
www.google.com/local?f=q&hl=en&q=6804+SW+Marine+Drive,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Botanical+Garden+and+Centre+for+Plant+Research+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageUBC Botanical Garden and Centre for Plant Research - 6804 SW Marine Drive, Vancouver, BC
University of British Columbia Botanical Garden curates a collection of ca. 12 000 plants representing approximately 8000 taxa from temperate regions around the world. Temperate forest plants of British Columbia, eastern North America and Asia are curated in woodland gardens, while a classic alpine garden displays the diverse flora of high-altitude regions of the world.
James Cowling, Booking & Administrative Coordinator (including Facility Rentals)
UBC Botanical Garden and Centre for Plant Research
6804 SW Marine Drive
Vancouver BC V6T 1Z4
Tel. 604 822-399z (Replace '9z' with '28')
Fax. 604 822-209z (Replace '9z' with '16')
tg@interchange.ubc.8m (Replace '8m' with 'ca')www.botanicalgarden.ubc.ca
www.google.com/local?f=q&hl=en&q=6804+SW+Marine+Drive,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Botanical+Garden+and+Centre+for+Plant+Research+Vancouver
Canadian Cancer Society - Regional head office - 230 - 3689 East 1st Avenue, Vancouver, BC
most trusted and respected voice on cancer and the best investment in the cancer cause;
* funding 38 outstanding cancer research projects in BC with the goal of eradicating cancer
* providing a range of caring personal and practical support programs to enhance the quality of life of people living with cancer
* leads with community action and health promotion to reduce preventable cancers in BC
Ron Kuehl, Vice President, Revenue Development
Canadian Cancer Society - Regional head office
230 - 3689 East 1st Avenue
Vancouver BC V5M 1C2
Tel. 604 253-849f (Replace '9f' with '70')
Fax. 604 253-849f (Replace '9f' with '03')
eatervan@bc.cancer.4s (Replace '4s' with 'ca')www.cancer.ca
In August 2008 The Canadian Cancer Society, BC & Yukon Division appointed Ron Kuehl as Vice President, Revenue Development.
Since taking up the position Ron has reorganized the Revenue Development department to reflect a new philosophy of giving based on a responsive relationship with donors. He is confident that the new approach is better given current fundraising challenges in the marketplace. “People have not stopped giving but we have to do a better job of showing that a donation to the Society is the best investment in the cancer cause and connect our donors and their giving with our mission," he said.
His expertise is needed to raise more funds to help combat the expected rise in cancer cases. With a proven track record in securing major and corporate gifts, Ron has already identified a high level donor to assist with a cornerstone contribution for a major capital project in northern BC, and secured a partnership with a national corporation to deliver prevention and support messaging and significant financial support.
Ron holds a Bachelor of Arts degree in Business Administration and Economics from Tabor College, Kansas, and honorary Doctorate from Regent University and is a member of the Association of Fundraising Professionals, and brings over 20 years of fundraising experience in the public and non-profit sectors to the Canadian Cancer Society.
Before joining the Canadian Cancer Society, Ron worked as the senior vice-president for external relations at Trinity Western University, was the senior director of development with Canuck Place Children's Hospice, the vice-president for advancement with Tabor College, and a marketing manager with the Canadian Broadcasting Corporation.
“Ron has been a welcome addition to our organization," said Barbara Kaminsky, CEO of the Canadian Cancer Society, B.C. and Yukon Division. “His demonstrated leadership in fundraising, marketing, and government relations helps us advance the Society's mission and vision throughout our division."
“Cancer has impacted my family and those of countless Canadians. There's a sense of urgency to respond and I can't think of a more worthwhile endeavour, nor a more exciting opportunity to serve," he added.
www.google.com/local?f=q&hl=en&q=230+-+3689+East+1st+Avenue,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Canadian+Cancer+Society+-+Regional+head+office+Vancouver
Canadian Cancer Society - Regional head office - 230 - 3689 East 1st Avenue, Vancouver, BC
most trusted and respected voice on cancer and the best investment in the cancer cause;
* funding 38 outstanding cancer research projects in BC with the goal of eradicating cancer
* providing a range of caring personal and practical support programs to enhance the quality of life of people living with cancer
* leads with community action and health promotion to reduce preventable cancers in BC
Cathy Adair, Vice President, Cancer Control
Canadian Cancer Society - Regional head office
230 - 3689 East 1st Avenue
Vancouver BC V5M 1C2
Tel. 604 253-84Ec (Replace 'Ec' with '70')
Fax. 604 253-84Ec (Replace 'Ec' with '03')
eatervan@bc.cancer.Ix (Replace 'Ix' with 'ca')www.cancer.ca
As the Vice President, Cancer Control, Cathy Adair is responsible for a broad portfolio comprising prevention; support services; research and policy, planning and evaluation across the Province and Yukon Territory. Under her management and guided by her expertise, the Canadian Cancer Society has developed of a five-year vision and strategic plan for the ongoing fight against cancer as the impact of cancer escalates with a growing and aging population.
She has made a significant contribution in her current role enhancing the Society's reputation and extending its influence on cancer issues that effect the population in BC and the Yukon. She leads and manages the Society's cancer prevention strategy that includes health promotion, community action and advocacy. Working with the CEO, Barbara Kaminsky and a team of prevention staff she has advanced the BC & Yukon Division as a leader in cancer prevention in Canada and influenced provincial and territorial governments.
Cathy is dedicated to ensuring individuals with cancer receive the services they need all along the cancer journey. She understands the Canadian Cancer Society's role includes not only direct service delivery in some areas, but important partnerships, advocacy where gaps exist and the provision of cancer information and services.
Cathy worked for the Canadian Cancer Society from 1995 through 2001, initially as Director Program Services and later as Director, Program Services & Regions. She said her commitment to cancer control, the strong leadership of Barbara Kaminksy and the passion of the people at the Society drew her back to this outstanding organization.
Her broad experience in social services and health services over 33 years was gained in developing and managing community based services in municipal, provincial, and not for profit organizations. Her appointments include Regional Director of Geriatric Mental Health Services, Ministry of Health (Fraser Valley); Continuing Care Manager, South Fraser Health Services; Director, Regional Coordination, Ministry of Health; Executive Director, Canadian Diabetes Association (BC & Yukon Division); and Executive Director Central City Care Society.
She has a Master Degree in Social Work and a certificate in Executive Development from UBC.
www.google.com/local?f=q&hl=en&q=230+-+3689+East+1st+Avenue,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Canadian+Cancer+Society+-+Regional+head+office+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageCanadian Cancer Society - Regional head office - 230 - 3689 East 1st Avenue, Vancouver, BC
most trusted and respected voice on cancer and the best investment in the cancer cause;
* funding 38 outstanding cancer research projects in BC with the goal of eradicating cancer
* providing a range of caring personal and practical support programs to enhance the quality of life of people living with cancer
* leads with community action and health promotion to reduce preventable cancers in BC
Barbara Kaminsky, Chief Executive Officer
Canadian Cancer Society - Regional head office
230 - 3689 East 1st Avenue
Vancouver BC V5M 1C2
Tel. 604 253-84ba (Replace 'ba' with '70')
Fax. 604 253-84ba (Replace 'ba' with '03')
eatervan@bc.cancer.E4 (Replace 'E4' with 'ca')www.cancer.ca
Barbara Kaminsky has made a significant contribution in cancer control in BC and the Yukon over the fifteen years that she has proficiently led the organization as Chief Executive Officer.
The Canadian Cancer Society BC and Yukon Division has evolved to become a leader in cancer prevention and cancer research funding, an influential advocate for cancer issues that affect the health of families and a responsive provider to the needs of people with cancer.
In the past decade and a half, the revenue of BC and Yukon Division has increased from $11.8 million in 1994 to $35.6 million in 2009. Both successful signature fundraising campaigns Relay For Life and Cops for Cancer now contribute some $10 million in income per year.
A number of mission-related accomplishments have taken place under her leadership including the expansion of Camp Goodtimes and the provision of a long term site for this innovative and accredited summer recreation program. A capital campaign delivered the funds to build a third residential lodge for cancer patients in the Interior in 1996 and currently a campaign is underway to construct the fourth lodge in Prince George coincident with the opening of a new cancer centre in 2012.
However it is clearly in the area of cancer prevention and cancer control where Barbara has excelled. Over the past decade, she has been instrumental in changing the way government agencies, health care professionals and individuals view cancer and their role in preventing it.
The media has come to recognize Barbara as the go to person for understandable commentary on cancer issues.
She has been an impassioned spokesperson on the importance of good health and protective behaviours to reduce the risk of cancer, and the responsibilities of governments to ensure healthy communities. Early on she recognized the need for a proactive approach to community inclusion.
As a champion of prevention, Barbara was instrumental in the development of a prevention strategy for BC and the Yukon and secured valuable partnerships with the BC Healthy Living Alliance and the Canadian Partnership Against Cancer. Under her leadership there were important changes to the Tobacco Act and the establishment of a Canadian Cancer Society Chair in Cancer Primary Prevention at UBC.
She was very successful in attracting donors and corporate supporters to contribute to prevention programs. More than $20 million has been invested in prevention and advocacy in the past five years,
Barbara is the current Chair of the Prevention Working Group for the Canadian Breast Cancer Foundation 2020 initiative-The Future without Breast Cancer and Past Chair of the Primary Prevention Action Group of the Canadian Partnership Against Cancer.
She considers leading the BC Healthy Living Alliance in developing The Winning Legacy-an evidence-based plan to assist the provincial government in realizing its dream of being the healthiest host of any Olympics-as a highlight of her career.
Barbara has authored several publications and studies on planning and resource allocation, which have been developed for use by the BC government and for Health Administration students. Most recently, she co-authored a book entitled, The Health Impact of Smoking & Obesity and what to do about it.
She took up the position with the Canadian Cancer Society in 1994 after working in healthcare management as Vice President of Clinical Services at Surrey Memorial Hospital; head of a health care management consulting group, and Administrator of Richmond's Long Term Care Program. Her first professional experience was in social work at Vancouver General Hospital.
In addition to certification as a health executive, Barbara has three degrees from the University of British Columbia-a BA in English, a Master of Social Work, and a Masters of Science in Health Services Planning and Administration. She is currently an adjunct professor at UBC.
www.google.com/local?f=q&hl=en&q=230+-+3689+East+1st+Avenue,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Canadian+Cancer+Society+-+Regional+head+office+Vancouver
UBC Centre for Drug Research and Development (CDRD) - 364 - 2259 Lower Mall, Vancouver, BC
enhances BC's productive life sciences community by creating a multi-disciplinary drug R&D platform comprising facilities, equipment, expertise, education and administration that is second-to-none in Canada;
aims to advance early stage health-related discoveries through the core activities of drug discovery, design and synthesis, screening, in vitro and in vivo testing, and drug formulation and evaluation;
provides a new research and training model that will broaden the B.C. pool of biotech entrepreneurs working on drug discovery and development;
unique hybrid organization that brings together researchers, institutions and industry to bridge the gap between primary research and the successful development of new medicines
Ms. Karimah Es Sabar, Senior Vice President, Business and Strategic Affairs
UBC Centre for Drug Research and Development (CDRD)
364 - 2259 Lower Mall
Vancouver BC V6T 1Z4
Tel. 604 221-775c (Replace '5c' with '50')
Fax. 604 221-775c (Replace '5c' with '53')
fo@cdrd.uu (Replace 'uu' with 'ca')www.cdrd.ca
www.linkedin.com/pub/karimah-es-sabar/3/a34/75a
June 27, 2011 - Providence Health Care Research Institute (PHCRI), home to several world-renowned research groups, has named Ms. Karimah Es Sabar as the new Chair of the Board of Trustees. In affiliation with the University of British Columbia, the Research Institute's main objective is to improve the health and treatment of patients and residents of Providence Health Care (PHC) through relevant, ethical and inspired health research.
Ms. Es Sabar, currently the Senior Vice President, Business and Strategic Affairs at The Centre for Drug Research and Development (CDRD), also serves as a board member for a number of organizations, including the Michael Smith Foundation for Health Research and The Vancouver Prostate Centre, a UBC and Vancouver General Hospital Centre of Excellence.
As the new Board Chair for PHCRI, Ms. Es Sabar brings with her strong ties to the local and international research communities as well as experience from her dynamic career in the life sciences industry.
Under the leadership of two exceptional past chairs, Dr. Simon Pimstone and Dr. Michael O'Shaughnessy, research funding at PHCRI has consistently grown over the past six years. PHCRI is the research arm of Providence Health Care, which includes laboratory, clinical and epidemiological research in several fields, such as HIV/AIDS, heart and lung disease, urban and mental health and elder care.
Ms. Es Sabar's appointment will support growth of scientific discovery and funding at PHCRI by furthering partnerships with the biotech community, government agencies and other research organizations throughout the Lower Mainland, the province and world.
Under Ms. Es Sabar's direction, Providence Health Care Research Institute will strive to reach new heights in exploring innovative areas of research and funding sources.
Prior to her current position at CDRD, Ms. Es Sabar led BC Biotech in re-engineering and rebranding the organization to LifeSciences BC. As President, she led the organization to its greatest level of success as a strong business development organization for the life science industry and the scientific research community.
Ms. Es Sabar has held senior management positions with international and multinational companies, most notably as Director, International Division and later Director, Marketing and Business Development at Connaught Laboratories Limited (now Sanofi Pasteur) based in Toronto.
More recently, Ms. Es Sabar was Vice President and Chief Operating Officer for Medsurge Medical and was the founder and managing director of SAL Healthcare Limited, a leading pharmaceutical marketing and distribution company based in Kenya.
Ms. Es Sabar received the CABE Award (Canada's Gold Award for Business Excellence) while at Sanofi Pasteur, was the recipient of the Women of Distinction Award in 2010 for Industry, Science and Technology, was listed on "The Vancouver Power 50" listing of the most influential people in BC as published by Business in Vancouver, and most recently on "BC's Top 100 Women of Influence" listing by the Vancouver Sun.
Ms. Es Sabar holds a BSc. Joint Honours Degree in Biochemistry/Chemistry from the University of Salford, England and a MSc. Degree in Neurochemistry from the Institute of Psychiatry, University of London, England.
www.google.com/local?f=q&hl=en&q=364+-+2259+Lower+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Centre+for+Drug+Research+and+Development+(CDRD)+Vancouver
UBC Centre for Drug Research and Development (CDRD) - 364 - 2259 Lower Mall, Vancouver, BC
enhances BC's productive life sciences community by creating a multi-disciplinary drug R&D platform comprising facilities, equipment, expertise, education and administration that is second-to-none in Canada;
aims to advance early stage health-related discoveries through the core activities of drug discovery, design and synthesis, screening, in vitro and in vivo testing, and drug formulation and evaluation;
provides a new research and training model that will broaden the B.C. pool of biotech entrepreneurs working on drug discovery and development;
unique hybrid organization that brings together researchers, institutions and industry to bridge the gap between primary research and the successful development of new medicines
Su Lee, Executive Assistant
UBC Centre for Drug Research and Development (CDRD)
364 - 2259 Lower Mall
Vancouver, BC V6T 1Z4
Tel. 604 221-77Zr (Replace 'Zr' with '50') X 103 - direct
Tel. 604 221-77Zr (Replace 'Zr' with '50')
Fax. 604 221-77Zr (Replace 'Zr' with '53')
ee@cdrd.RX (Replace 'RX' with 'ca')fo@cdrd.RX (Replace 'RX' with 'ca')www.cdrd.ca
www.google.com/local?f=q&hl=en&q=364+-+2259+Lower+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Centre+for+Drug+Research+and+Development+(CDRD)+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageUBC Centre for Drug Research and Development (CDRD) - 364 - 2259 Lower Mall, Vancouver, BC
enhances BC's productive life sciences community by creating a multi-disciplinary drug R&D platform comprising facilities, equipment, expertise, education and administration that is second-to-none in Canada;
aims to advance early stage health-related discoveries through the core activities of drug discovery, design and synthesis, screening, in vitro and in vivo testing, and drug formulation and evaluation;
provides a new research and training model that will broaden the B.C. pool of biotech entrepreneurs working on drug discovery and development;
unique hybrid organization that brings together researchers, institutions and industry to bridge the gap between primary research and the successful development of new medicines
Shelly Kean, Special Projects Coordinator
UBC Centre for Drug Research and Development (CDRD)
364 - 2259 Lower Mall
Vancouver, BC V6T 1Z4
Tel. 604 420-70Yt (Replace 'Yt' with '89') - direct
Tel. 604 221-77Yt (Replace 'Yt' with '50')
Fax. 604 221-77Yt (Replace 'Yt' with '53')
ean@cdrd.JI (Replace 'JI' with 'ca')fo@cdrd.JI (Replace 'JI' with 'ca')www.cdrd.ca
www.google.com/local?f=q&hl=en&q=364+-+2259+Lower+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Centre+for+Drug+Research+and+Development+(CDRD)+Vancouver
UBC Centre for Drug Research and Development (CDRD) - 364 - 2259 Lower Mall, Vancouver, BC
enhances BC's productive life sciences community by creating a multi-disciplinary drug R&D platform comprising facilities, equipment, expertise, education and administration that is second-to-none in Canada;
aims to advance early stage health-related discoveries through the core activities of drug discovery, design and synthesis, screening, in vitro and in vivo testing, and drug formulation and evaluation;
provides a new research and training model that will broaden the B.C. pool of biotech entrepreneurs working on drug discovery and development;
unique hybrid organization that brings together researchers, institutions and industry to bridge the gap between primary research and the successful development of new medicines
Pieter Cullis, Ph.D, FRSC, Scientific Director
UBC Centre for Drug Research and Development (CDRD)
Professor, Department of Biochemistry and Molecular Biology, Life Sciences Centre, UBC
364 - 2259 Lower Mall
Vancouver, BC V6T 1Z4
Tel. 604 221-77y7 (Replace 'y7' with '50') X 105 - direct
Tel. 604 221-77y7 (Replace 'y7' with '50')
Fax. 604 221-77y7 (Replace 'y7' with '53')
eterc@interchange.ubc.tq (Replace 'tq' with 'ca')fo@cdrd.tq (Replace 'tq' with 'ca')www.cdrd.ca
Dr. Cullis is a Professor in the Department of Biochemistry and Molecular Biology, UBC, and Chief Scientific Officer and Senior Vice President, Research, at Inex Pharmaceuticals Corporation. His laboratory is focused on the development of liposomal systems for delivery of conventional and genetic drugs.
This work has led to two products that have been approved by regulatory agencies for the treatment of cancer and its complications. Dr. Cullis has published over 250 scientific articles and is an inventor on over 30 patents.
Dr. Cullis was awarded the B.C. Science Council Gold Medal for Health Sciences in 1991, the international Alec D. Bangham Award in 2000 and the B.C. Biotechnology Association Award for Innovation and Achievement in 2002. He was elected to the Royal Society of Canada in 2004.
www.google.com/local?f=q&hl=en&q=364+-+2259+Lower+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Centre+for+Drug+Research+and+Development+(CDRD)+Vancouver
UBC Centre for Drug Research and Development (CDRD) - 364 - 2259 Lower Mall, Vancouver, BC
enhances BC's productive life sciences community by creating a multi-disciplinary drug R&D platform comprising facilities, equipment, expertise, education and administration that is second-to-none in Canada;
aims to advance early stage health-related discoveries through the core activities of drug discovery, design and synthesis, screening, in vitro and in vivo testing, and drug formulation and evaluation;
provides a new research and training model that will broaden the B.C. pool of biotech entrepreneurs working on drug discovery and development;
unique hybrid organization that brings together researchers, institutions and industry to bridge the gap between primary research and the successful development of new medicines
Natalie Dakers, Founder and Chief Executive Officer
UBC Centre for Drug Research and Development (CDRD)
364 - 2259 Lower Mall
Vancouver, BC V6T 1Z4
Tel. 604 221-77j2 (Replace 'j2' with '50') X 102 - direct
Tel. 604 221-77j2 (Replace 'j2' with '50')
Fax. 604 221-77j2 (Replace 'j2' with '53')
akers@cdrd.GD (Replace 'GD' with 'ca')fo@cdrd.GD (Replace 'GD' with 'ca')www.cdrd.ca
Ms. Dakers was President & CEO of Neuromed Technologies Inc., a private biopharmaceutical company developing drugs for chronic pain, anxiety, epilepsy and cardiovascular diseases.
As co-founder, she built the company from inception and raised three rounds of venture financing totaling approximately $70 million. Under her leadership, the company filed its first Investigational New Drug (IND) application for a novel chronic pain drug and commenced Phase 1 clinical trials.
Prior to co-founding Neuromed, Ms. Dakers was a Senior Manager for life sciences technology transfer at the University Industry Liaison Office (UILO) at the University of British Columbia. In this capacity, she was involved in the creation and spin-off of more than a dozen start-up high-tech and biotech companies.
Ms. Dakers served as Chair of BC Biotech, the association representing and promoting the province's biotech firms. From 1999 to 2001, she served as a board member of AceTech Academy of Technology CEOs. Ms. Dakers has also served as Vice-President of the Association of University Technology Managers and as Director of the Premier's Advisory Council of Science and Technology.
After graduating from University of Guelph with an honours degree in marine biology, Dakers worked as a research biologist for a B.C. salmon aquaculture company. In 1989, she joined UBC's University-Industry Liaison Office (UILO) where, as senior manager for life sciences technology transfer, she learned about venture financing, licensing agreements and the complex world of commercialization.
I was lucky enough to work with creative people in an office that was leading the way in tech transfer in Canada, says Dakers.
She acknowledges that there are strong and polarized feelings on commercialization -- some believe it doesn't fit with the research and education mandate of a university.
If you do it right, you can enhance a university's reputation, she says. A spin-off is the vehicle to enable discovery.
After eight years and helping to create more than a dozen spin-offs, Dakers decided she had done enough facilitating and wanted to get in the game.
She had worked with UBC neurobiologist Terry Snutch on some research contracts and was impressed with his stellar science. He has developed compounds to block calcium channels in the brain that transmit pain signals. The drugs are aimed at patients with chronic pain and other severe neurological disorders, such as epilepsy.
The pair -- with no formal business training between them -- launched Neuromed Technologies Inc. in 1998 to commercialize Snutch's ideas in developing pain-killing drugs.
Early on I could have simply licensed out the technology and walked away, says Snutch. It's been a very long road but the experience has been worth all the effort - there hasn't been a dull moment. And although there's still a long way to go, we based Neuromed on solid scientific rationale and never wavered from the original concept of drug development as the best way to create and maintain value.
I jumped in and never looked back, says Dakers. We were passionate about what we were doing. We never lost faith.
But their faith was tested. In January 2002, the first compound failed at a critical point in the financing process. It was one of the sickening plummets in what Dakers calls the roller-coaster ride of running a spin-off. She spent a year getting investors excited once again about the venture and the second compound they were set to try.
By January 2003, she had raised a total of $70 million for Neuromed, which propelled it toward what she describes as her proudest moment -- when the first clinical trial participants received doses of calcium channel blockers.
But with that success came a very difficult decision. In October 2003, Neuromed had secured the third round of financing. The agreement with lead investor, MPM Capital, meant the company would have a new CEO operating from the U.S. Dakers had to let go of Neuromed, although the research base remains in Vancouver and Snutch continues as vice-president and chief scientific officer.
www.google.com/local?f=q&hl=en&q=364+-+2259+Lower+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Centre+for+Drug+Research+and+Development+(CDRD)+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageUBC Centre for Drug Research and Development (CDRD) - 364 - 2259 Lower Mall, Vancouver, BC
enhances BC's productive life sciences community by creating a multi-disciplinary drug R&D platform comprising facilities, equipment, expertise, education and administration that is second-to-none in Canada;
aims to advance early stage health-related discoveries through the core activities of drug discovery, design and synthesis, screening, in vitro and in vivo testing, and drug formulation and evaluation;
provides a new research and training model that will broaden the B.C. pool of biotech entrepreneurs working on drug discovery and development;
unique hybrid organization that brings together researchers, institutions and industry to bridge the gap between primary research and the successful development of new medicines
Kathryn Hayashi, Chief Financial Officer
UBC Centre for Drug Research and Development (CDRD)
364 - 2259 Lower Mall
Vancouver, BC V6T 1Z4
Tel. 604 221-77of (Replace 'of' with '50') X 104 - direct
Tel. 604 221-77of (Replace 'of' with '50')
Fax. 604 221-77of (Replace 'of' with '53')
ayashi@cdrd.d4 (Replace 'd4' with 'ca')fo@cdrd.d4 (Replace 'd4' with 'ca')www.cdrd.ca
www.google.com/local?f=q&hl=en&q=364+-+2259+Lower+Mall,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=UBC+Centre+for+Drug+Research+and+Development+(CDRD)+Vancouver
Ondine Biomedical Inc. - 888 - 1100 Melville Street, Vancouver, BC
developing non-antibiotic, light-activated technology therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections primarily for the healthcare-associated infection (HAI) market;
photodisinfection products providing rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance
Carolyn Cross, MBA, Chartered Financial Analyst, Chairman and Chief Executive Officer
Ondine Biomedical Inc.
888 - 1100 Melville Street
Vancouver BC V6E 4A6
Tel. 604 669-05Rl (Replace 'Rl' with '55')
Fax. 604 669-05Rl (Replace 'Rl' with '33')
ross@ondinebio.czT (Replace 'zT' with 'om')www.ondinebio.com
Ms. Cross was one of the initial founders and financial supporters of Ondine Biomedical Inc. in 1999 and currently serves as the Chairman of the board and Chief Executive Officer the Company.
Ms. Cross has over 18 years direct experience working with early stage companies and has 25 years experience with public market securities. Previously, Ms. Cross was responsible for managing pension, pooled, mutual and private client funds as a Vice President with Royal Bank Investment Management Inc., the fund management arm of the Royal Bank of Canada.
She currently sits on the boards of a number of companies including Periowave Dental Technologies, Inc., OrGenX Biopharma Corp., and Sinuwave Technologies Corp, and sits on the Advisory Board of the McGill University Dental School.
Ms Cross is a member of the Women's Presidents Organization, the International Women's Forum, the Toronto Society of Financial Analysts, and the Courthill and Cherie Blair Foundations. Ms Cross is the Founder of OrGenX Biopharma Corporation, a WEConnect (www.weconnectcanada.org) certified company.
www.google.com/local?f=q&hl=en&q=888+-+1100+Melville+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Ondine+Biomedical+Inc.+Vancouver
Med BioGene Inc. - 1500 - 701 West Georgia Street, Vancouver, BC
development and commercialization of genomic-based clinical laboratory diagnostic tests;
Med BioGene's lead test under development is LungExpress Dx, a proprietary 15-gene signature to improve upon staging for identifying those patients with early-stage non-small-cell lung cancer who, following surgical removal of their tumor, are at a higher and lower risk of mortality
Erinn B. Broshko, Chief Executive Officer
Med BioGene Inc.
1500 - 701 West Georgia Street
Vancouver BC V7Y 1C6
Tel. 800 641-35vG (Replace 'vG' with '93')
Fax. 888 646-25vG (Replace 'vG' with '31')
roshko@medbiogene.cAY (Replace 'AY' with 'om')www.medbiogene.com
www.google.com/local?f=q&hl=en&q=1500+-+701+West+Georgia+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Med+BioGene+Inc.+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageOndine Biomedical Inc. - 888 - 1100 Melville Street, Vancouver, BC
developing non-antibiotic, light-activated technology therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections primarily for the healthcare-associated infection (HAI) market;
photodisinfection products providing rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance
Cale Street, Ph.D., MBA, Vice President, Research
Ondine Biomedical Inc.
888 - 1100 Melville Street
Vancouver BC V6E 4A6
Tel. 604 669-057t (Replace '7t' with '55')
Fax. 604 669-057t (Replace '7t' with '33')
www.ondinebio.com
PhD, Experimental Surgery - University of Alberta
B.Sc. Pharmacology - University of Alberta
MBA - University of Washington
Dr. Street's research career spans several different fields in both academic and industrial settings. He was a member of the Islet Transplant Group at the University of Alberta, contributing to the development and optimization of the “Edmonton Protocol" now accepted worldwide as a treatment alternative for end-stage type 1 diabetes. Dr. Street also was involved with research relating to tissue response to implanted biomaterials and biological response of the skin to mechanical stress in the Bioengineering Department at the University of Washington.
Dr. Street is responsible for the company's internal and external preclinical research programs in the field of antimicrobial photodynamic therapy, and is the leader of the MRSAid program. Dr. Street has published multiple original research articles in peer-reviewed scientific journals, and is named as an inventor on 7 U.S. patent applications related to photodynamic therapy (PDT).
www.google.com/local?f=q&hl=en&q=888+-+1100+Melville+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Ondine+Biomedical+Inc.+Vancouver
Ondine Biomedical Inc. - 888 - 1100 Melville Street, Vancouver, BC
developing non-antibiotic, light-activated technology therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections primarily for the healthcare-associated infection (HAI) market;
photodisinfection products providing rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance
William S. Harper, MBA, CA, Chief Financial Officer, Vice President Finance & Corporate Secret
Ondine Biomedical Inc.
888 - 1100 Melville Street
Vancouver BC V6E 4A6
Tel. 604 669-05mE (Replace 'mE' with '55')
Fax. 604 669-05mE (Replace 'mE' with '33')
www.ondinebio.com
Mr. Harper is a professional accountant with more than 25 years experience in corporate finance and administration, including senior management positions with public companies listed in both Canada and the United States, primarily in the mining and high technology industries.
Prior to joining Ondine Biomedical, he was the chief financial officer and corporate secretary of several public companies listed on the TSX Venture Exchange.
www.google.com/local?f=q&hl=en&q=888+-+1100+Melville+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Ondine+Biomedical+Inc.+Vancouver
Ondine Biomedical Inc. - 888 - 1100 Melville Street, Vancouver, BC
developing non-antibiotic, light-activated technology therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections primarily for the healthcare-associated infection (HAI) market;
photodisinfection products providing rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance
Thomas Dawson, MBA, B.A.Sc., Chief Operating Officer
Ondine Biomedical Inc.
888 - 1100 Melville Street
Vancouver BC V6E 4A6
Tel. 604 669-054q (Replace '4q' with '55')
Fax. 604 669-054q (Replace '4q' with '33')
www.ondinebio.com
Mr. Dawson has over 20 years experience developing and commercializing new products, implementing operational best practices, lean enterprise systems, and managing P&L responsibility for sensor & instrument, telecom, medical device, and electronics firms. Prior to joining Ondine, Tom held the position of Vice President of Operations for DuxArea, Inc., President of Kistler-Morse Corporation, a subsidiary of Danaher Corporation, and Vice President and General Manager of Leviton Voice and Data, a division of Leviton Manufacturing Company.
One of the original employees of the start-up business unit, Tom also held the position of Director of M&S, IT, Product Development, HR and Operations. He has managed multiple sites including the U.S., Mexico and Europe. Tom is a member of the Beta Gamma Sigma Honor Society, and lectures at various academic institutions.
www.google.com/local?f=q&hl=en&q=888+-+1100+Melville+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Ondine+Biomedical+Inc.+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageOndine Biomedical Inc. - 888 - 1100 Melville Street, Vancouver, BC
developing non-antibiotic, light-activated technology therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections primarily for the healthcare-associated infection (HAI) market;
photodisinfection products providing rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance
Nicolas G. Loebel, Ph.D, Chief Technology Officer and President
Ondine Biomedical Inc.
888 - 1100 Melville Street
Vancouver BC V6E 4A6
Tel. 604 669-05k3 (Replace 'k3' with '55')
Fax. 604 669-05k3 (Replace 'k3' with '33')
www.ondinebio.com
PhD Biomedical Engineering - University of Washington
Master's Biomedical Engineering - University of Washington
BSAA, Aeronautical Engineering - University of Washington
Dr. Loebel serves as President and Chief Technology Officer to the Company in the area of photochemistry, photoexcitation and optical energy delivery systems.
His research focus has centered on the rheological modeling of periodontal disease and tooth mobility, and in fiber optic waveguide propagation theory, evanescent coupling and the applications of optical fibers to interferometric sensors.
He has experience in pharmaceutical and medical products manufacturing, corporate management and business development in public market environments. He has authored several publications and patents in the area of interferometric and fluorimetric fiber sensors.
Dr. Loebel also serves as a director of Environmental Sensors, Inc., and lectures regularly on photodynamics around the world.
www.google.com/local?f=q&hl=en&q=888+-+1100+Melville+Street,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Ondine+Biomedical+Inc.+Vancouver
Augurex Life Sciences Corp. - 887 Great Northern Way, Vancouver, BC
develops biomarker technologies to screen people for diseases that when identified can be promptly treated, thereby delivering the benefit of earlier detection and greater treatment success; technology to detect early stage arthritis;
Biomarker screening tools to optimize a person's therapy by predicting which treatment will personally offer them maximum therapeutic benefit while minimizing their side effects
Norma K. Biln, Chief Executive Officer and Co-Founder
Augurex Life Sciences Corp.
887 Great Northern Way
Vancouver BC V5T 4T5
Tel. 778 839-33I5 (Replace 'I5' with '19')
Fax. 604 988-14I5 (Replace 'I5' with '25')
iln@augurex.cIT (Replace 'IT' with 'om')www.augurex.com
Norma Biln has brought strategic and operational execution excellence to each position she has held along her career. Throughout her 14 years in the life sciences she has worked along, built and led teams that have consistently exceeded financial goals by capitalizing on the strengths within her team.
Norma began her career in clinical research with Pfizer Pharmaceuticals after completing her Bachelor of Science in Physiology at McGill University. She continued her career in several capacities in sales management, marketing and market access with Pfizer Pharmaceuticals, Amgen and Abbott Laboratories where she won several regional and national level awards for top performance in each role.
She later joined Stressgen Biotechnologies as Director of Corporate Market Development working on HSP-E7, a therapeutic cervical cancer vaccine. At Stressgen, she also held the position of Director of Sales and Marketing for the bioreagent business where during her tenure, she was instrumental in developing a strategic business plan that substantially grew sales at a mature stage within the company's life cycle.
Since July 2005 Norma has worked as a consultant with Aspreva Pharmaceuticals on Business Development, Commercial and Communications initiatives. In addition to her Bachelor of Science, she holds a Master of Business Administration from the University of Phoenix.
The scope Norma has gained of the life sciences through her industry experience across several functional and disease areas along with her proven ability to strategically plan, execute and deliver results through garnering the expertise of key individuals will set Augurex up for success as it develops its product portfolio.
www.google.com/local?f=q&hl=en&q=887+Great+Northern+Way,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Augurex+Life+Sciences+Corp.+Vancouver
Augurex Life Sciences Corp. - 887 Great Northern Way, Vancouver, BC
develops biomarker technologies to screen people for diseases that when identified can be promptly treated, thereby delivering the benefit of earlier detection and greater treatment success; technology to detect early stage arthritis;
Biomarker screening tools to optimize a person's therapy by predicting which treatment will personally offer them maximum therapeutic benefit while minimizing their side effects
Anthony Marotta, Chief Scientific Officer and Co-Founder
Augurex Life Sciences Corp.
887 Great Northern Way
Vancouver BC V5T 4T5
Tel. 778 839-33pF (Replace 'pF' with '19')
Fax. 604 988-14pF (Replace 'pF' with '25')
arotta@augurex.cBh (Replace 'Bh' with 'om')www.augurex.com
Anthony Marotta's scientific creativity and knowledge have consistently created progressive opportunities that have delivered great returns for companies that he has been involved with.
Anthony began his career in research at Kinetek Pharmaceuticals while completing his Ph.D. in Experimental Medicine at the University of British Columbia. He then co-founded BioSun Solutions, a consulting firm focused on providing business development and marketing services in the biotechnology industry.
Anthony later joined Stressgen Bioreagents as the technical services manager where he tactically grew the product portfolio by 30% through developing strategic collaborations.
He played a key role in training lab, sales and technical staff and was involved in several aspects of the day-to-day operations of the whole business.
He was appointed to Director, Business Development when Stressgen was acquired by a venture capital firm to later be merged with Assay Designs. During the M&A transition Anthony was an asset to the organization from a business development, sales and operational standpoint.
Anthony's experience at the bench as well as within bioreagent business development are a great asset in tapping in to key opinion leader expertise, industry lab access and assessing technological opportunities as Augurex forms key collaborations in product development.
www.google.com/local?f=q&hl=en&q=887+Great+Northern+Way,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=Augurex+Life+Sciences+Corp.+Vancouver
Find better employment faster with the JobPro British Columbia Employers Directory, and get connected to the industries, companies and the people running them of greatest value to you.
Add or update company & contact information, or send feedback to directory maintainers.
Top of pageCollege of Pharmacists of British Columbia - 200 - 1765 West 8th Avenue, Vancouver, BC
ensure British Columbia pharmacists provide safe and effective pharmacy care to help people achieve better health, responsible for administering provincial pharmacy legislation;
protect public health by licensing and regulating pharmacists and the places where pharmacists practise;
responsible for making sure every pharmacist is fully qualified and able to provide the public with competent care
Lori DeCou, Communications Director
College of Pharmacists of British Columbia
200 - 1765 West 8th Avenue
Vancouver BC V6J 5C6
Tel. 604 733-24Av (Replace 'Av' with '40')
Fax. 604 733-24Av (Replace 'Av' with '93')
ri.decou@bcpharmacists.oER (Replace 'ER' with 'rg')fo@bcpharmacists.oER (Replace 'ER' with 'rg')www.bcpharmacists.org
www.linkedin.com/pub/lori-decou/14/3ba/7b8
Lori DeCou was Director of Communications at Best Buy Canada Ltd. and Future Shop prior to becoming Communications Director at the College of Pharmacists of British Columbia.
www.google.com/local?f=q&hl=en&q=200+-+1765+West+8th+Avenue,+Vancouver,+BC
www.jobprodirectory.com/download.html
www.google.ca/#hl=en&q=College+of+Pharmacists+of+British+Columbia+Vancouver
